education organization

King's College London

GB

People

Connected researchers

Public evidence

158 connected articles

The association between cannabis use and brain reward anticipation: a 12-month longitudinal study of adults and adolescents who use cannabis and age-matched controls2026 · PubMed Central Open Access Cannabis-Based Medicinal Products for Endometriosis: A 2-Year Prospective Analysis From the UK Medical Cannabis Registry.2026 · PubMed Central Open Access Changes in cannabis potency and cannabis-related psychiatric harms: a 23-year ecological study in Denmark.2026 · Europe PMC UK Medical Cannabis Registry: an updated analysis of clinical outcomes of medicinal cannabis therapy for hypermobility-associated chronic pain2026 · PubMed Central Open Access UK Medical Cannabis Registry: a case series analysing clinical outcomes of medicinal cannabis therapy for fibromyalgia.2026 · Europe PMC Real-world effectiveness of antipsychotic medication in relapse prevention after cannabis-induced psychosis.2026 · Europe PMC A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis-Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry.2026 · Europe PMC Health education interventions to reduce cannabis and tobacco smoking-related harms among people who use cannabis: a systematic review.2026 · Europe PMC Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study.2025 · Europe PMC UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Epilepsy.

Registered research

Connected studies

A Visuomotor Rotation Task as a Biomarker of Cerebellar Dysfunction in Chronic Cannabis Usenct03662737 Body Project SMIL: Effectiveness of Virtually Delivered Body Project Groups to Prevent Eating Disorders Among Young Women With Psychiatric Illnessnct06893627 Do Adolescents and Adults Differ in Their Acute Subjective, Behavioural and Neural Responses to Cannabis, With and Without Cannabidiol?nct04851392 Does Cannabidiol Attenuate the Acute Effects of ∆9-tetrahydrocannabinol Intoxication in Individuals Diagnosed With Schizophrenia? A Double-blind, Randomised, Placebo-controlled Experimental Studynct04605393 Effects of Cannabidiol (CBD) on the Brainnct04831294 Evaluating the Efficacy of Cannabidiol for Reducing Cigarette Usenct06218056 Fetal Exposure to Cannabinoids: Exposure, Methylation and Neurodevelopmental Effectsnct04422600 Personalized Feedback Intervention to Reduce Risky Cannabis Use: Randomized Controlled Trialnct04060602 Testing the Efficacy of the Cannabis Clinic for Patients With Psychosis (CCP) Intervention for Cannabis Use Reduction/Cessation in Patients With First Episode Psychosisnct07245212

Matched by exact identifiers only. Profile data: OpenAlex.

2025 · Europe PMC

Does cannabidiol reduce the adverse effects of cannabis in schizophrenia? A randomised, double-blind, cross-over trial.2025 · Europe PMC

The impact of childhood trauma and cannabis use on paranoia: a structural equation model approach.2025 · Europe PMC

Applying machine learning to international drug monitoring: classifying cannabis resin collected in Europe using cannabinoid concentrations.2025 · Europe PMC

International perspectives on physician knowledge, attitudes, and practices related to medical cannabis.2025 · Europe PMC

DNA methylation profiles of long-term cannabis users in midlife: a comprehensive evaluation of published cannabis-associated methylation markers in a representative cohort.2025 · Europe PMC

Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents.2025 · Europe PMC

Associations of Cannabis Use, High-Risk Alcohol Use, and Depressive Symptomology with Motivation and Attempts to Quit Cigarette Smoking Among Adults: Findings from the 2020 ITC Four Country Smoking and Vaping Survey.2025 · Europe PMC

Are reasons for first using cannabis associated with subsequent cannabis consumption (standard THC units) and psychopathology?2025 · Europe PMC

Methylomic signature of current cannabis use in two first-episode psychosis cohorts.2025 · Europe PMC

Mood instability as a transdiagnostic predictor of cannabis use in attention-deficit/hyperactivity disorder and depression: A natural language processing analysis of electronic health records from 13,025 adolescents.2025 · Europe PMC

Value signals guiding choices for cannabis versus non-drug rewards in people who use cannabis near-daily.2025 · Europe PMC

Rare but relevant: Cannabis use and myocardial infarction.2025 · Europe PMC

UK medical cannabis registry: A clinical outcome analysis of medical cannabis therapy in chronic pain patients with and without co-morbid sleep impairment.2025 · Europe PMC

UK Medical Cannabis Registry: An Analysis of Outcomes of Medical Cannabis Therapy for Hypermobility-Associated Chronic Pain.2025 · Europe PMC

Factors Influencing Co-Use of Tobacco and Cannabis Amongst Young Adults in UK Further Education Colleges: A Qualitative Study.2025 · Europe PMC

The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies.2024 · Europe PMC

A cohort study comparing the effects of medical cannabis for anxiety patients with and without comorbid sleep disturbance.2024 · Europe PMC

Assessing rates and predictors of cannabis-associated psychotic symptoms across observational, experimental and medical research.2024 · Europe PMC

Cannabis use and cognitive biases in people with first-episode psychosis and their siblings.2024 · Europe PMC

Support Provided by Stop-Smoking Practitioners to Co-users of Tobacco and Cannabis: A Qualitative Study.2024 · Europe PMC